Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Maidstone

Maidstone, United KingdomNot linked to an institution yet

3running trials
3closed trials
0trials confirmed by the site in the last 60 days
–languages not stated

The site has not confirmed any trial yet.

Running trials

Active, not recruiting
A Study of Osimertinib With or Without Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer (FLAURA2)
NCT04035486· Phase 3· Source
Active, not recruiting
A Study of Acalabrutinib vs Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in R/R CLL
NCT02970318· Phase 3· Source
Active, not recruiting
Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma
NCT01843374· Phase 2· Source

Researchers

No researcher is linked here yet.

Closed trials

Recruiting
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
NCT07291037· Phase 3· Source
Completed
Olaparib Real-world Utilization and Clinical Outcomes in France, Italy, and the UK
NCT04532645· Source
Completed
AZD9291 Versus Gefitinib or Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
NCT02296125· Phase 3· Source

Site data: ClinicalTrials.govUpdated 11 Nov 2026

Report an error